Dr. Ritesh R. Kotecha, MD

  • New York, NY
  • Hematologist and oncologist
NPI1396159703PAC ID6901113653
Medicare services, 2024
703
Medicare patients, 2024
198
Part D claims, 2024
624
Publications
54
Clinical trials
3
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 5 affiliations

Find Dr. Kotecha's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Ritesh R. Kotecha is a hematologist and oncologist in New York, New York

Dr. Kotecha practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Kotecha's NPI, 1396159703, was assigned on June 12, 2014. Dr. Kotecha graduated from Albany Medical College in 2014. Dr. Kotecha holds New York license 288258.

NPI and contact details
Medicare PAC ID
6901113653
NPI enumeration date
June 12, 2014
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
38
Medical school graduation
2014

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Ritesh R. Kotecha practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Kotecha's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Ritesh R. Kotecha is affiliated with 1 site of care and 4 medical groups

Dr. Kotecha's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Kotecha to 3 more medical groups, each named with a free account.

See all 5 affiliations for Dr. Kotecha

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Ritesh R. Kotecha's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kotecha practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Kotecha practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Ritesh R. Kotecha is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Kotecha's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kotecha is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kotecha's licenses on file in 5 states: New York, Florida, New Jersey, Pennsylvania and Massachusetts.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 288258 · 2017 to 2026 · taxonomy 207RH0003X
  • Florida licenseSince 2021
  • New Jersey license2020 to 2027
  • Pennsylvania license2023 to 2026
  • Massachusetts license2014 to 2017

Clinical focus

Dmand AI lists lymphoma and prostate cancer among the conditions Dr. Kotecha treats.

Hematologists and oncologists near Dr. Kotecha

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Ritesh R. Kotecha billed Medicare for 703 services in 2024

CMS data shows 703 Medicare services from Dr. Kotecha across 5 procedure codes in 2024, for 198 Medicare patients. Medicare paid $65,451 for them.

Medicare services, 2024703
Medicare patients198
Paid by Medicare$65,451
Procedure codes5

Dr. Kotecha's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5422024: 70330%

Where Dr. Kotecha's Medicare services took place, 2024

  • In an office65393%
  • In a facility507%

Dr. Kotecha compared with the New York median for hematologists and oncologists, 2024

  • Dr. Kotecha
  • New York median
Medicare services
703vs 6685% above
Medicare patients
198vs 2106% below
Part D claims
417vs 25862% above

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Kotecha's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kotecha

Need commercial claims for Dr. Kotecha?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kotecha and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Ritesh R. Kotecha treated 198 Medicare patients in 2024, average age 75

CMS counts 198 Medicare patients who saw Dr. Kotecha in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have cancer, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kotecha's median patient age at 74, with 15% women.

Medicare patients, 2024198
Average age75
Average risk score2.56
Also on Medicaid11%

Dr. Kotecha's Medicare patients by age, 2024

Dr. Kotecha's Medicare patients by sex, 2024

  • Women2814%
  • Men17086%

Chronic conditions among Dr. Kotecha's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Arthritis48%
  5. Chronic kidney disease43%
  6. Ischemic heart disease40%
  7. Diabetes35%
  8. Anxiety28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kotecha's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women15%
  • Men85%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Ritesh R. Kotecha wrote 624 Medicare Part D claims in 2024

In 2024, Dr. Kotecha wrote 624 Medicare Part D claims for 92 patients. 67% of them were for generic drugs. CMS names the drug for 417 of them, across 14 drugs with 11 or more claims each, at $3,353,513 in total drug cost. In 2023, CMS named 400 claims across 11 drugs.

Part D claims, 2024624
Drugs named by CMS14
Total drug cost$3.4M
Part D patients92

Dr. Kotecha's Part D claims by kind of drug, 2024

  • Generic419 claims67%
  • Brand-name and other205 claims33%

Dr. Kotecha's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kotecha's Part D claims, 2024

  • Opioids3%16 of 624 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4002024: 4174%

Drugs named by CMS: 14 in 2024, 11 in 2023.

See all prescribing by Dr. Kotecha

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Ritesh R. Kotecha scored 80 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Kotecha for performance year 2024, reported as part of a group. Dr. Kotecha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kotecha as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Kotecha's MIPS scores, performance year 2024

  • 80of 100Final score
  • 71.5of 100Quality
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Kotecha by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Ritesh R. Kotecha has 54 publications on record

Dmand AI links 54 papers to Dr. Kotecha, published from 2011 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Immunotherapy. Dr. Kotecha has published most often in Eur Urol. Dr. Kotecha's most frequent co-authors are Martin Henner Voss, MD, Robert J. Motzer, MD and Maria I. Carlo, MD.

Papers54
Years published2011 to 2025

Dr. Kotecha's papers by year, 2011 to 2025

Topics Dr. Kotecha writes about most

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Immunotherapy
  • Antineoplastic Combined Chemotherapy Protocols
  • Biomarkers, Tumor
  • Nephrectomy
  • Nivolumab
  • Genomics

Dr. Kotecha's most frequent co-authors

Recent publications by Dr. Kotecha

See all 54 publications and co-authors

See who Dr. Kotecha researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kotecha works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Ritesh R. Kotecha has worked on 3 clinical trials

Dmand AI links Dr. Kotecha to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Renal Cell and Kidney Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 3.

Clinical trials with Dr. Kotecha by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 1/2: 1 trial
  3. 1Phase 2: 1 trial
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Kotecha's trials

  • Carcinoma, Renal Cell
  • Kidney Neoplasms

Investigators on the most trials with Dr. Kotecha

Recent clinical trials with Dr. Kotecha

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Ritesh R. Kotecha received $8,374 in industry payments from 2021 to 2025

CMS Open Payments shows 18 general payments to Dr. Kotecha from 5 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 83% of the total. Eisai Inc. paid the most, $7,266.

General payments to Dr. Kotecha by program year, 2021 to 2025

General payments to Dr. Kotecha by kind, 2021 to 2025

$8.4Kin total
  • Consulting fees$6,93083%
  • Food and beverage$1,41617%
  • Travel and lodging$280%

Companies that paid Dr. Kotecha the most, 2021 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kotecha

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Ritesh R. Kotecha graduated from Albany Medical College

Dr. Kotecha graduated from Albany Medical College in 2014.

  1. Medical schoolAlbany Medical College
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Ritesh R. Kotecha accepts plans from 8 insurance carriers

Dr. Kotecha is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.

  • Aetna
  • Excellus BlueCross BlueShield
  • Blue Cross Blue Shield of Michigan
  • Elevance
  • Blue Cross Blue Shield of Massachusetts
  • HCSC
  • CMS Medicare
  • NY State Medicaid

Plan types Dr. Kotecha accepts, by number of carriers

  1. Medicare6
  2. PPO6
  3. POS4
  4. EPO3
  5. HMO3
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Ritesh R. Kotecha's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Ritesh R. Kotecha

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Ritesh R. Kotecha's NPI number?

Dr. Ritesh R. Kotecha's NPI number is 1396159703. It was assigned on June 12, 2014, and it is active in the NPI Registry.

What kind of doctor is Dr. Ritesh R. Kotecha?

Dr. Ritesh R. Kotecha is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Ritesh R. Kotecha practice?

Dr. Kotecha practices at 1275 York Avenue, New York, NY 10065. Dr. Kotecha's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Kotecha to 3 medical groups.

What is Dr. Ritesh R. Kotecha's medical license number?

Dr. Kotecha holds New York license 288258, one of the licenses on file in 5 states.

Which states has Dr. Ritesh R. Kotecha been licensed in?

Dmand AI has state licenses on file for Dr. Kotecha in New York (2017 to 2026), Florida (since 2021), New Jersey (2020 to 2027), Pennsylvania (2023 to 2026) and Massachusetts (2014 to 2017).

Which hospitals is Dr. Ritesh R. Kotecha affiliated with?

Dr. Kotecha practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Ritesh R. Kotecha part of?

Dr. Kotecha is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Kotecha to 3 more medical groups.

Does Dr. Ritesh R. Kotecha accept Medicare?

Yes. CMS data shows Dr. Kotecha billed Medicare for 703 services in 2024, and Dr. Kotecha accepts Medicare assignment.

Does Dr. Ritesh R. Kotecha offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Kotecha as offering telehealth services.

What is Dr. Ritesh R. Kotecha's MIPS score?

Dr. Kotecha's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Ritesh R. Kotecha see?

CMS counts 198 Medicare patients who saw Dr. Kotecha in 2024, with an average age of 75.

Is Dr. Ritesh R. Kotecha board certified?

Yes. Dr. Kotecha is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Ritesh R. Kotecha bill to Medicare?

In 2024, Dr. Kotecha's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).

Where did Dr. Ritesh R. Kotecha go to medical school?

Dr. Kotecha graduated from Albany Medical College in 2014.

What drugs does Dr. Ritesh R. Kotecha prescribe most?

In 2024 Medicare Part D data, Dr. Kotecha's most prescribed drugs by claims were Levothyroxine Sodium, Cabometyx and Prednisone.

Has Dr. Ritesh R. Kotecha received payments from drug or device companies?

CMS Open Payments shows $8,374 in general payments to Dr. Kotecha from 5 companies from 2021 to 2025. The largest total came from Eisai Inc.

How long has Dr. Ritesh R. Kotecha been practicing?

Dr. Kotecha graduated from medical school in 2014, 12 years ago.

Does Dr. Ritesh R. Kotecha do research?

Dmand AI links 54 publications to Dr. Kotecha, published from 2011 to 2025. Dr. Kotecha has worked on 3 clinical trials.

Who does Dr. Ritesh R. Kotecha publish with?

Dr. Kotecha's most frequent co-authors are Martin Henner Voss, MD (31 shared papers), Robert J. Motzer, MD (30 shared papers) and Maria I. Carlo, MD (20 shared papers).

What insurance does Dr. Ritesh R. Kotecha accept?

Dr. Kotecha is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)